Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / WETG - WeTrade stock rises 11% on $50M sales contract for monkeypox test kits

WETG - WeTrade stock rises 11% on $50M sales contract for monkeypox test kits

Wet Engineering Bhd

  • WeTrade Group ( NASDAQ: WETG ) said it will sell monkeypox virus test kits and antigen tests for $50M to Parkway Medical.
  • Under the agreement, Parkway agreed to buy 5M units of nucleic acid test (RT-LAMP) and 6M units of antigen tests (Colloidal Golden Technique) for a total worth $50M, and Parkway has paid $1M as deposit.
  • "We are excited about the sales of monkeypox virus kits and antigen tests to Parkway Medical after obtaining the exclusive sales channel from Jiqing Biomedical Technology Co. Ltd," said WeTrade CEO  Pijun Liu.
  • WETG +11.19% to $16.00 premarket Aug. 12

For further details see:

WeTrade stock rises 11% on $50M sales contract for monkeypox test kits
Stock Information
Company Name: Wet Engineering Bhd
Stock Symbol: WETG
Market: OTC
Menu
WETG WETG Quote WETG Short WETG News WETG Articles WETG Message Board
Get WETG Alerts

News, Short Squeeze, Breakout and More Instantly...